The Use of Intralipid Infusions in the Prevention of Embryo Implantation Failure
Intralipids have been suggested to suppress uterine natural killer cell activity, which could potentially improve implantation rates in women with recurrent loss. We report a case of a 41-year-old African woman with recurrent pregnancy loss who had elevated uterine killer cell activity and for whom...
Gespeichert in:
Veröffentlicht in: | Curēus (Palo Alto, CA) CA), 2024-02, Vol.16 (2), p.e53368 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 2 |
container_start_page | e53368 |
container_title | Curēus (Palo Alto, CA) |
container_volume | 16 |
creator | Anya, Okorie C Ajayi, Eniola R Solanke, Henry R Ohanaka, Adaeze I Ubana, Kokei D |
description | Intralipids have been suggested to suppress uterine natural killer cell activity, which could potentially improve implantation rates in women with recurrent loss. We report a case of a 41-year-old African woman with recurrent pregnancy loss who had elevated uterine killer cell activity and for whom intralipid infusion was used to achieve pregnancy. We recommend routine uterine natural killer cell testing for women with recurrent pregnancy loss and further research on newer intravenous lipid emulsions in fertility medicine. |
doi_str_mv | 10.7759/cureus.53368 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_3020718241</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3020718241</sourcerecordid><originalsourceid>FETCH-LOGICAL-c211t-5b9a1fe10cda0530bf437063e06ae72d10187208d70ab43b6cb7676fca8c6caa3</originalsourceid><addsrcrecordid>eNpNkM1LAzEQxYMoVmpvnmXBq1tnNrtJepTSaqFgD-05ZLMJbtkvk12h_73ph-JpHo8fb2YeIQ8IU86z2YsenBn8NKOUiStylyATsUCRXv_TIzLxfg8ACDwBDrdkREVKM0zpHdlsP0208yZqbbRqeqeqsiuLIO3gy7bxUdlEfUA2znybpg_WkVzUuTu00aruKtX06mQvVVmFa-7JjVWVN5PLHJPdcrGdv8frj7fV_HUd6wSxj7N8ptAaBF0oyCjkNqUcGDXAlOFJgYAiXCsKDipPac50zhlnViuhmVaKjsnTObdz7ddgfC_37eCasFJSCG-iSFIM1POZ0q713hkrO1fWyh0kgjw2KM8NylODAX-8hA55bYo_-Lcv-gO23Gyj</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3020718241</pqid></control><display><type>article</type><title>The Use of Intralipid Infusions in the Prevention of Embryo Implantation Failure</title><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Anya, Okorie C ; Ajayi, Eniola R ; Solanke, Henry R ; Ohanaka, Adaeze I ; Ubana, Kokei D</creator><creatorcontrib>Anya, Okorie C ; Ajayi, Eniola R ; Solanke, Henry R ; Ohanaka, Adaeze I ; Ubana, Kokei D</creatorcontrib><description>Intralipids have been suggested to suppress uterine natural killer cell activity, which could potentially improve implantation rates in women with recurrent loss. We report a case of a 41-year-old African woman with recurrent pregnancy loss who had elevated uterine killer cell activity and for whom intralipid infusion was used to achieve pregnancy. We recommend routine uterine natural killer cell testing for women with recurrent pregnancy loss and further research on newer intravenous lipid emulsions in fertility medicine.</description><identifier>ISSN: 2168-8184</identifier><identifier>EISSN: 2168-8184</identifier><identifier>DOI: 10.7759/cureus.53368</identifier><identifier>PMID: 38435143</identifier><language>eng</language><publisher>United States: Cureus Inc</publisher><subject>Antibodies ; Antigens ; Blood groups ; Cardiac arrest ; Case reports ; Embryos ; Endometrium ; Fertility ; Genotype & phenotype ; Hepatitis ; HIV ; Human immunodeficiency virus ; Immune system ; In vitro fertilization ; Intensive care ; Lipids ; Lymphocytes ; Menstruation ; Nutrition ; Ovaries ; Parenteral nutrition ; Patients ; Pregnancy ; Serology ; Sperm ; Tumor necrosis factor-TNF</subject><ispartof>Curēus (Palo Alto, CA), 2024-02, Vol.16 (2), p.e53368</ispartof><rights>Copyright © 2024, Anya et al.</rights><rights>Copyright © 2024, Anya et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c211t-5b9a1fe10cda0530bf437063e06ae72d10187208d70ab43b6cb7676fca8c6caa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38435143$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Anya, Okorie C</creatorcontrib><creatorcontrib>Ajayi, Eniola R</creatorcontrib><creatorcontrib>Solanke, Henry R</creatorcontrib><creatorcontrib>Ohanaka, Adaeze I</creatorcontrib><creatorcontrib>Ubana, Kokei D</creatorcontrib><title>The Use of Intralipid Infusions in the Prevention of Embryo Implantation Failure</title><title>Curēus (Palo Alto, CA)</title><addtitle>Cureus</addtitle><description>Intralipids have been suggested to suppress uterine natural killer cell activity, which could potentially improve implantation rates in women with recurrent loss. We report a case of a 41-year-old African woman with recurrent pregnancy loss who had elevated uterine killer cell activity and for whom intralipid infusion was used to achieve pregnancy. We recommend routine uterine natural killer cell testing for women with recurrent pregnancy loss and further research on newer intravenous lipid emulsions in fertility medicine.</description><subject>Antibodies</subject><subject>Antigens</subject><subject>Blood groups</subject><subject>Cardiac arrest</subject><subject>Case reports</subject><subject>Embryos</subject><subject>Endometrium</subject><subject>Fertility</subject><subject>Genotype & phenotype</subject><subject>Hepatitis</subject><subject>HIV</subject><subject>Human immunodeficiency virus</subject><subject>Immune system</subject><subject>In vitro fertilization</subject><subject>Intensive care</subject><subject>Lipids</subject><subject>Lymphocytes</subject><subject>Menstruation</subject><subject>Nutrition</subject><subject>Ovaries</subject><subject>Parenteral nutrition</subject><subject>Patients</subject><subject>Pregnancy</subject><subject>Serology</subject><subject>Sperm</subject><subject>Tumor necrosis factor-TNF</subject><issn>2168-8184</issn><issn>2168-8184</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpNkM1LAzEQxYMoVmpvnmXBq1tnNrtJepTSaqFgD-05ZLMJbtkvk12h_73ph-JpHo8fb2YeIQ8IU86z2YsenBn8NKOUiStylyATsUCRXv_TIzLxfg8ACDwBDrdkREVKM0zpHdlsP0208yZqbbRqeqeqsiuLIO3gy7bxUdlEfUA2znybpg_WkVzUuTu00aruKtX06mQvVVmFa-7JjVWVN5PLHJPdcrGdv8frj7fV_HUd6wSxj7N8ptAaBF0oyCjkNqUcGDXAlOFJgYAiXCsKDipPac50zhlnViuhmVaKjsnTObdz7ddgfC_37eCasFJSCG-iSFIM1POZ0q713hkrO1fWyh0kgjw2KM8NylODAX-8hA55bYo_-Lcv-gO23Gyj</recordid><startdate>20240201</startdate><enddate>20240201</enddate><creator>Anya, Okorie C</creator><creator>Ajayi, Eniola R</creator><creator>Solanke, Henry R</creator><creator>Ohanaka, Adaeze I</creator><creator>Ubana, Kokei D</creator><general>Cureus Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20240201</creationdate><title>The Use of Intralipid Infusions in the Prevention of Embryo Implantation Failure</title><author>Anya, Okorie C ; Ajayi, Eniola R ; Solanke, Henry R ; Ohanaka, Adaeze I ; Ubana, Kokei D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c211t-5b9a1fe10cda0530bf437063e06ae72d10187208d70ab43b6cb7676fca8c6caa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Antibodies</topic><topic>Antigens</topic><topic>Blood groups</topic><topic>Cardiac arrest</topic><topic>Case reports</topic><topic>Embryos</topic><topic>Endometrium</topic><topic>Fertility</topic><topic>Genotype & phenotype</topic><topic>Hepatitis</topic><topic>HIV</topic><topic>Human immunodeficiency virus</topic><topic>Immune system</topic><topic>In vitro fertilization</topic><topic>Intensive care</topic><topic>Lipids</topic><topic>Lymphocytes</topic><topic>Menstruation</topic><topic>Nutrition</topic><topic>Ovaries</topic><topic>Parenteral nutrition</topic><topic>Patients</topic><topic>Pregnancy</topic><topic>Serology</topic><topic>Sperm</topic><topic>Tumor necrosis factor-TNF</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Anya, Okorie C</creatorcontrib><creatorcontrib>Ajayi, Eniola R</creatorcontrib><creatorcontrib>Solanke, Henry R</creatorcontrib><creatorcontrib>Ohanaka, Adaeze I</creatorcontrib><creatorcontrib>Ubana, Kokei D</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Curēus (Palo Alto, CA)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Anya, Okorie C</au><au>Ajayi, Eniola R</au><au>Solanke, Henry R</au><au>Ohanaka, Adaeze I</au><au>Ubana, Kokei D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Use of Intralipid Infusions in the Prevention of Embryo Implantation Failure</atitle><jtitle>Curēus (Palo Alto, CA)</jtitle><addtitle>Cureus</addtitle><date>2024-02-01</date><risdate>2024</risdate><volume>16</volume><issue>2</issue><spage>e53368</spage><pages>e53368-</pages><issn>2168-8184</issn><eissn>2168-8184</eissn><abstract>Intralipids have been suggested to suppress uterine natural killer cell activity, which could potentially improve implantation rates in women with recurrent loss. We report a case of a 41-year-old African woman with recurrent pregnancy loss who had elevated uterine killer cell activity and for whom intralipid infusion was used to achieve pregnancy. We recommend routine uterine natural killer cell testing for women with recurrent pregnancy loss and further research on newer intravenous lipid emulsions in fertility medicine.</abstract><cop>United States</cop><pub>Cureus Inc</pub><pmid>38435143</pmid><doi>10.7759/cureus.53368</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2168-8184 |
ispartof | Curēus (Palo Alto, CA), 2024-02, Vol.16 (2), p.e53368 |
issn | 2168-8184 2168-8184 |
language | eng |
recordid | cdi_proquest_journals_3020718241 |
source | PubMed Central Open Access; PubMed Central |
subjects | Antibodies Antigens Blood groups Cardiac arrest Case reports Embryos Endometrium Fertility Genotype & phenotype Hepatitis HIV Human immunodeficiency virus Immune system In vitro fertilization Intensive care Lipids Lymphocytes Menstruation Nutrition Ovaries Parenteral nutrition Patients Pregnancy Serology Sperm Tumor necrosis factor-TNF |
title | The Use of Intralipid Infusions in the Prevention of Embryo Implantation Failure |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T09%3A22%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Use%20of%20Intralipid%20Infusions%20in%20the%20Prevention%20of%20Embryo%20Implantation%20Failure&rft.jtitle=Cur%C4%93us%20(Palo%20Alto,%20CA)&rft.au=Anya,%20Okorie%20C&rft.date=2024-02-01&rft.volume=16&rft.issue=2&rft.spage=e53368&rft.pages=e53368-&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759/cureus.53368&rft_dat=%3Cproquest_cross%3E3020718241%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3020718241&rft_id=info:pmid/38435143&rfr_iscdi=true |